<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20140810018754N10</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-11-29</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of high power laser in chronic lateral epicondylitis</public_title>
      <acronym></acronym>
      <scientific_title>The effect of high power laser with exercise versus sham high power laser with exercise versus high power laser on pain, grip strength and function in patients with chronic lateral epicondylitis.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-11-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>75</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/43091</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Method: simple - unit: personal- by using sealed envelope
Participants will be randomly assigned to 3 groups(intervention NO1.; intervention NO2. and control groups) by drawing a sealed envelope in which the number of one of the groups is written from a box. After completing a group it`s envelope will be put away, Blinding description: The participants will be unaware of classification and to prevent of  the participants communication, timing will arrange carefully. In the control group,  the Laser set will be off.  Assessor will be kept unaware and will be  asked to do just evaluation and abstrain of any answer and question.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic Lateral Epicondylitis.</hc_freetext>
      <i_freetext>Intervention 1: In the intervention group NO.1, intervention includes high power laser therapy and exercise. The laser parameters are: power 7 W.; energy dose 10 j/cm2; duty cycle 50%. In the first session that is a warm up the laser dose will be 5 j/cm2 and in the next ten sessions the laser dose will be 10 j/cm2. Subjects will be evaluated before the warm up; at the end of the first; fifth; tenth sessions and after 3 months follow up. During the each session, in sitting position, elbow in extension and forearm in pronation after safety precautions the treatment area will be demarcated then the laser probe will be moved along the long axis and transverse to the tendon. Exercise includes static stretching followed by eccentric exercise of wrist extensors. Stretching exercise will be performed in seated position with elbow extension  and forearm pronation and wrist flexion with ulnar deviation.Stretch force will be applied by therapist according to the participant tolerance for 30 to 45 seconds and 3 times  before and 3 times after eccentric exercise with 30 seconds rest between each stretch. Eccentric exercise will be performed in the seated position with elbow extension, forearm pronation and maximum wrist extension. Then the participant slowly  will lower the wrist in to the flexion for a count of 30. Using the contralateral hand to return to the started position. 3 set of 10 repetition will be performed during each session with a one minute rest interval between each set for 10 sessions every other day. Intervention 2: Intervention group NO.2:This group receives high power laser( with the protocol as mentioned in group NO.1( laser power 5W; laser dosage 5J/CM2 in the warm up session and 10J/cm2 in the 10 treatment sessions )without exercises. Due to ethical considerations subjects will be offered the exercise after 3 months follow up. Intervention 3: Control group: In this group the laser unit will be off and the exercise program will be performed as the program in the intervention group NO.1. Due to ethical considerations the subjects will be offered the true treatment after 3 month follow up.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data or results of the present study will be presented in an article or some articles that will be published after  completing the study.

When:
After completing the present study and publishing the resulting article or articles

To whom:
All researchers in the field of the present study

Conditions:
With the same goal as the present study and with  mention of the present study as the reference. All intellectual property rights of the present study belongs to the Iran University of Medical Sciences.

Where to obtain:
The corresponding author of the article or articles derived from this study

How to obtain:
Written request from the author responsible for the present review after the publication of the resulting article or articles.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sarrafzadeh Javad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Physiotherapy department, School of Rehabilitation Sciences, Madadkaran St., Shahnazari St., Madar Squ., Mirdamad St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>+98 21 2222 8051</telephone>
        <email>sarrafzadeh.j@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Sarrafzadeh Javad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Physiotherapy department, School of Rehabilitation Sciences, Madadkaran St., Shahnazari St., Madar squ., Mirdamad St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>+98 21 2222 8051</telephone>
        <email>sarrafzadeh.j@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>History of the symptoms between 3 to 6 months
Exacerbating the pain on lateral aspect of elbow by gripping
2 of 3 positive results of Mills-Cozen and Maudsley tests
Tenderness with palpation of lateral epicondylitis</inclusion_criteria>
      <agemin>35 years</agemin>
      <agemax>55 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Cervical radiculopathy, neuropathy and myelopathy
Any type of treatment; drugs, local injections and  physiotherapy within the past 3 months
History of upper extremity surgical treatment
Deformity and fractures of the humerus and elbow joint bones
Pregnancy
Rheumatic disease
Photosensitivity</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M77.10</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Chronic Lateral Epicondylitis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>In the intervention group NO.1, intervention includes high power laser therapy and exercise. The laser parameters are: power 7 W.; energy dose 10 j/cm2; duty cycle 50%. In the first session that is a warm up the laser dose will be 5 j/cm2 and in the next ten sessions the laser dose will be 10 j/cm2. Subjects will be evaluated before the warm up; at the end of the first; fifth; tenth sessions and after 3 months follow up. During the each session, in sitting position, elbow in extension and forearm in pronation after safety precautions the treatment area will be demarcated then the laser probe will be moved along the long axis and transverse to the tendon. Exercise includes static stretching followed by eccentric exercise of wrist extensors. Stretching exercise will be performed in seated position with elbow extension  and forearm pronation and wrist flexion with ulnar deviation.Stretch force will be applied by therapist according to the participant tolerance for 30 to 45 seconds and 3 times  before and 3 times after eccentric exercise with 30 seconds rest between each stretch. Eccentric exercise will be performed in the seated position with elbow extension, forearm pronation and maximum wrist extension. Then the participant slowly  will lower the wrist in to the flexion for a count of 30. Using the contralateral hand to return to the started position. 3 set of 10 repetition will be performed during each session with a one minute rest interval between each set for 10 sessions every other day.</i_keyword>
      <i_keyword>Intervention group NO.2:This group receives high power laser( with the protocol as mentioned in group NO.1( laser power 5W; laser dosage 5J/CM2 in the warm up session and 10J/cm2 in the 10 treatment sessions )without exercises. Due to ethical considerations subjects will be offered the exercise after 3 months follow up.</i_keyword>
      <i_keyword>Control group: In this group the laser unit will be off and the exercise program will be performed as the program in the intervention group NO.1. Due to ethical considerations the subjects will be offered the true treatment after 3 month follow up.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: Before warm up session ,at the end of the first, fifth, tenth sessions and after 3 months. Method of measurement: VAS=visual analog scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Hand grip strength. Timepoint: Before warm up session, at the end of first, fifth,tenth,sessions and after 3  months follow up. Method of measurement: Dynamometer.</sec_outcome>
      <sec_outcome>Function. Timepoint: Before warm up session; at the end of first; fifth; tenth sessions and after  3 months follow up. Method of measurement: PRTEE Questionair= Patient Rated Tennis Elbow Evaluation.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-09-14</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Scienses</contact_name>
        <contact_address>5th Floor, Iran University of Medical Science, next to Milad Tower, Hemmat Highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
